The Lennox-Gastaut Syndrome (LGS) Market focuses on treatments and therapies for managing this severe and rare form of epilepsy, typically starting in childhood. LGS is characterized by multiple types of seizures, intellectual disability, and a high degree of resistance to standard anti-seizure […]
Read More>>